All PlansAdministrativeMedium impact
Recall: Semglee
UPMC Health Plan·Endocrinology, Family Medicine, Internal Medicine +1 more·Pharmacy
We identified it
Jun 20, 2026
Summary
Mylan Pharmaceuticals is recalling a specific batch of Semglee insulin glargine injection 3mL prefilled pens due to safety concerns. Healthcare practices should immediately check their inventory and discontinue use of affected products.
Action Required
Immediately: Check all pharmacy inventory for Semglee insulin glargine injection 3mL prefilled pens from the recalled batch. Remove any affected products from inventory and do not dispense to patients. Notify patients who may have received recalled products and coordinate alternative insulin prescriptions with providers.